1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
ImmunityBio, Inc.

ImmunityBio, Inc.

IBRX
ImmunityBio, Inc.US flagNASDAQ Global Select
7.32
USD
+0.10
- -
7.67BMarket Cap

Income Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
2
1
1
- -
1
15
113
+ Sales & Services Revenue
2
1
1
- -
1
15
113
- Cost of Revenue
- -
- -
- -
- -
- -
- -
1
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
1
Gross Profit
- -
- -
- -
- -
1
15
113
+ Other Operating Income
-2
-1
-1
- -
- -
- -
- -
- Operating Expenses
158
211
331
351
362
359
369
+ Selling, General & Admin
46
71
135
103
130
169
150
+ Research & Development
112
140
196
248
232
190
219
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-156
-210
-330
-351
-361
-344
-256
- Non-Operating (Income) Loss
4
16
20
67
223
69
96
+ Interest Expense, Net
3
7
14
44
86
129
110
+ Interest Expense
6
9
15
47
87
132
113
- Interest Income
3
2
1
3
1
2
3
+ Other Non-Op (Income) Loss
1
8
6
22
137
-60
-14
Pretax Income
-160
-226
-350
-417
-584
-414
-352
- Income Tax Expense (Benefit)
- -
-2
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-160
-224
-350
-417
-584
-414
-351
- Net Extraordinary Losses (Gains)
-5
-5
-6
-2
-1
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
-5
-5
-6
-2
-1
- -
- -
Income (Loss) Incl. MI
-155
-220
-344
-416
-583
-413
-351
- Minority Interest
2
2
3
1
1
- -
- -
Net Income, GAAP
-158
-222
-347
-417
-583
-414
-351
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-158
-222
-347
-417
-583
-414
-351
EBIT
-156
-210
-330
-351
-361
-344
-256
EBITDA
-142
-197
-316
-332
-343
-327
-241
EBITDA Margin (%)
-6,458.17
-32,641.49
-33,837.47
-138,482.08
-55,120.9
-2,215.18
-212.29
EBITA
-156
-210
-330
-351
-361
-344
-256
Gross Margin (%)
100
100
100
100
100
100
99.34
Operating Margin (%)
-7,095.87
-34,747.11
-35,361.88
-146,090.42
-58,097.11
-2,334.23
-226
Profit Margin (%)
-7,165.17
-36,669.59
-37,129.55
-173,569.58
-93,761.41
-2,804.77
-310.18
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
14
13
14
18
19
18
16
Basic Weighted Avg Shares
383
383
389
400
509
697
920
Basic EPS, GAAP
-0.41
-0.58
-0.89
-1.04
-1.15
-0.59
-0.38
Basic EPS from Cont Ops
-0.42
-0.59
-0.9
-1.04
-1.15
-0.59
-0.38
Diluted Weighted Avg Shares
383
383
389
400
509
700
920
Diluted EPS, GAAP
-0.41
-0.58
-0.89
-1.04
-1.15
-0.59
-0.38
Diluted EPS from Cont Ops
-0.42
-0.59
-0.9
-1.04
-1.15
-0.59
-0.38

Balance Sheet (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
- -
112
334
141
294
185
315
+ Cash, Cash Equivalents & STI
- -
96
317
107
266
150
243
+ Cash & Cash Equivalents
- -
35
181
105
265
143
88
+ ST Investments
- -
61
136
3
1
6
154
+ Accounts & Notes Receiv
- -
2
1
2
3
3
43
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
2
43
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
2
1
2
3
- -
- -
+ Inventories
- -
- -
- -
- -
- -
8
1
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
8
- -
+ Finished Goods
- -
- -
- -
- -
- -
1
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
1
+ Other ST Assets
- -
14
16
32
24
24
29
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
110
135
222
210
198
187
+ Property, Plant & Equip, Net
- -
91
119
189
183
170
147
+ Property, Plant & Equip
- -
133
172
259
267
270
260
- Accumulated Depreciation
- -
42
53
69
84
100
112
+ LT Investments & Receivables
- -
11
8
1
1
- -
- -
+ LT Investments
- -
11
8
1
1
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
8
8
31
27
28
40
+ Total Intangible Assets
- -
1
1
20
17
16
14
+ Goodwill
- -
- -
- -
- -
- -
1
1
+ Other Intangible Assets
- -
1
1
20
17
15
13
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
6
6
11
10
12
26
Total Assets
- -
221
469
362
504
383
502
+ Payables & Accruals
- -
45
50
47
35
31
31
+ Accounts Payable
- -
12
11
21
9
7
7
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
34
39
26
26
25
24
+ ST Debt
- -
5
302
435
5
7
8
+ ST Borrowings
- -
- -
299
432
- -
- -
- -
+ ST Finance Leases
- -
5
3
3
5
7
8
+ Other ST Liabilities
- -
18
17
20
18
16
23
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
18
17
20
18
16
23
Total Current Liabilities
- -
68
369
501
58
55
62
+ LT Debt
- -
271
343
289
721
497
511
+ LT Borrowings
- -
254
306
241
682
462
477
+ LT Finance Leases
- -
16
37
48
40
35
33
+ Other LT Liabilities
- -
1
- -
22
311
319
429
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
1
- -
22
311
319
429
Total Noncurrent Liabilities
- -
272
344
311
1,032
816
940
Total Liabilities
- -
340
713
812
1,090
871
1,001
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
1,495
1,720
1,931
2,375
2,885
3,197
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
1,495
1,720
1,931
2,375
2,885
3,197
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
- -
-1,615
-1,962
-2,378
-2,962
-3,375
-3,727
+ Other Equity
- -
- -
- -
- -
- -
1
29
Equity Before Minority Interest
- -
-120
-242
-447
-587
-489
-500
+ Minority/Non Controlling Interest
- -
1
-2
-2
1
1
1
Total Equity
- -
-118
-244
-450
-586
-488
-500
Total Liabilities & Equity
- -
221
469
362
504
383
502
Shares Outstanding
- -
383
398
422
671
853
1,012
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
21
40
51
45
42
41
Net Debt
- -
219
424
569
416
318
389
Net Debt to Equity
- -
-185.2
-174.03
-126.39
-71.01
-65.24
-77.82
Tangible Common Equity Ratio
- -
-54.54
-52.48
-137.23
-123.73
-137.35
-105.24
Current Ratio
- -
1.64
0.91
0.28
5.05
3.36
5.1
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
2,676.16

Cash Flow Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-160
-224
-350
-417
-584
-414
-351
+ Depreciation & Amortization
14
13
14
18
19
18
16
+ Non-Cash Items
10
23
80
70
195
24
85
+ Stock-Based Compensation
3
2
57
40
49
34
37
+ Deferred Income Taxes
- -
-3
- -
- -
- -
- -
- -
+ Asset Impairment Charge
2
11
- -
2
1
- -
14
+ Other Non-Cash Adj
5
13
23
27
145
-10
35
+ Chg in Non-Cash Work Cap
-16
16
-19
-8
4
-19
-54
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
-2
-40
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
-8
-6
+ (Inc) Dec in Prepaid Assets
6
4
-2
-17
6
2
-5
+ Inc (Dec) in Accts Payable
-11
15
1
12
- -
-5
3
+ Inc (Dec) in Other
-11
-3
-18
-4
-2
-6
-6
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-152
-172
-274
-338
-367
-391
-305
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
20
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
20
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-4
-2
-34
-99
-31
-7
-4
+ Acq of Fixed Prod Assets
-4
-2
-34
-78
-31
-7
-4
+ Acq of Intangible Assets
- -
- -
- -
-21
- -
- -
- -
+ Cash (Repurchase) of Equity
27
86
165
60
101
111
401
+ Increase in Capital Stock
30
86
165
60
101
111
401
+ Decrease in Capital Stock
-3
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
25
-18
-72
128
- -
-4
-146
+ Dec in LT Investment
112
74
70
162
10
137
96
+ Inc in LT Investment
-87
-92
-142
-34
-10
-141
-241
+ Net Cash From Acq & Div
- -
- -
- -
-1
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
-1
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
-2
- -
- -
- -
- -
-1
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
19
-20
-85
27
-30
-12
-150
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
48
64
677
348
259
- -
3
+ Cash From Debt
48
64
677
348
259
- -
3
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
39
1
-336
-175
199
170
-3
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
114
151
505
234
558
282
400
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-19
-41
146
-77
161
-122
-54
EBITDA
-142
-197
-316
-332
-343
-327
-241
EBITDA Margin (%)
-6,458.17
-32,641.49
-33,837.47
-138,482.08
-55,120.9
-2,215.18
-212.29
Free Cash Flow
-156
-173
-308
-437
-397
-398
-309
Net Cash Paid for Acquisitions
- -
- -
- -
1
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-110
390
-67
-139
-398
-306
Free Cash Flow per Basic Share
-0.41
-0.45
-0.79
-1.09
-0.78
-0.57
-0.34
Price/Free Cash Flow
-9.82
-30.04
-9.83
-8.51
-7.6
-4.67
-6.06
Cash Flow to Net Income
0.96
0.77
0.79
0.81
0.63
0.95
0.87
Capital Expenditures
-4
-2
-34
-99
-31
-7
-4